{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "endurance",
      "exercise",
      "insulin-like growth factor",
      "myostatin",
      "nuclear receptors",
      "resistance",
      "skeletal muscle"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24033098",
  "DateCompleted": {
    "Year": "2014",
    "Month": "11",
    "Day": "06"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/bph.12399"
    ],
    "Journal": {
      "ISSN": "1476-5381",
      "JournalIssue": {
        "Volume": "170",
        "Issue": "6",
        "PubDate": {
          "Year": "2013",
          "Month": "Nov"
        }
      },
      "Title": "British journal of pharmacology",
      "ISOAbbreviation": "Br J Pharmacol"
    },
    "ArticleTitle": "Mechanisms governing the health and performance benefits of exercise.",
    "Pagination": {
      "StartPage": "1153",
      "EndPage": "1166",
      "MedlinePgn": "1153-66"
    },
    "Abstract": {
      "AbstractText": [
        "Humans are considered among the greatest if not the greatest endurance land animals. Over the last 50 years, as the population has become more sedentary, rates of cardiovascular disease and its associated risk factors such as obesity, type 2 diabetes and hypertension have all increased. Aerobic fitness is considered protective for all-cause mortality, cardiovascular disease, a variety of cancers, joint disease and depression. Here, I will review the emerging mechanisms that underlie the response to exercise, focusing on the major target organ the skeletal muscle system. Understanding the mechanisms of action of exercise will allow us to develop new therapies that mimic the protective actions of exercise."
      ],
      "CopyrightInformation": "\u00a9 2013 The British Pharmacological Society."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Comparative Biomedical Sciences, The Royal Veterinary College, London, UK."
          }
        ],
        "LastName": "Bishop-Bailey",
        "ForeName": "D",
        "Initials": "D"
      }
    ],
    "GrantList": [
      {
        "GrantID": "PG/11/39/28890",
        "Acronym": "BHF_",
        "Agency": "British Heart Foundation",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Br J Pharmacol",
    "NlmUniqueID": "7502536",
    "ISSNLinking": "0007-1188"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Cytoplasmic and Nuclear"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Physical Endurance"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Receptors, Cytoplasmic and Nuclear"
    }
  ]
}